Intron Biotechnology signs MTA with European biotech firm for 'pHyal20' SC platform
Predicted impact: Low
Material transfer agreement for a platform; no financial terms disclosed.
048530 · KOSDAQ · ₩048530 · 인트론바이오
Predicted impact: Low
Material transfer agreement for a platform; no financial terms disclosed.
Predicted impact: Low
Material transfer agreement for a platform technology; small and vague commercially.
Also known as: iNtRON Biotechnology / 인트론바이오 / 048530 / KRX:048530
Source: KRX statistical information